Correction to: Signal Transduction and Targeted Therapy https://doi.org/10.1038/s41392-022-00970-8, published online 27 May 2022
In this article, the funding from “National Natural Science Foundation of China to YR (Grant# 82125034), National Key R&D Program of China (#2020YFE0202200, #2021YFA1300200).” was omitted.
The original article has been corrected.
About this article
Cite this article
Zhong, T., Sun, X., Yu, L. et al. Correction: PROTAC mediated FKBP12 degradation enhances Hepcidin expression via BMP signaling without immunosuppression activity. Sig Transduct Target Ther 7, 197 (2022). https://doi.org/10.1038/s41392-022-01051-6